Your browser doesn't support javascript.
loading
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆.
Di Filippo, Y; Dalle, S; Mortier, L; Dereure, O; Dalac, S; Dutriaux, C; Leccia, M-T; Legoupil, D; Saiag, P; Brunet-Possenti, F; Arnnault, J-P; Maubec, E; Granel-Brocard, F; De Quatrebarbes, J; Aubin, F; Lesimple, T; Beylot-Barry, M; Stoebner, P-E; Dupuy, A; Stephan, A; Grob, J-J; Lefevre, W; Oriano, B; Allayous, C; Lebbé, C; Montaudié, H.
Afiliação
  • Di Filippo Y; Dermatology Department, University Hospital of Nice, and INSERM U1065, Centre Méditerranéen de Médecine Moléculaire, Université Côte d'Azur, Nice, France.
  • Dalle S; Hospices Civils De Lyon, Cancer Research Center of Lyon, Pierre-Bénite, France.
  • Mortier L; Dermatology Department, University of Lille, Lille, France.
  • Dereure O; Dermatology Department, University Hospital of Montpellier, Montpellier, France.
  • Dalac S; Dermatology Department, University Hospital of Dijon, Dijon, France.
  • Dutriaux C; Dermatology Department, Bordeaux Hospital, Bordeaux, France.
  • Leccia MT; Dermatology Department, University of Grenoble, Grenoble, France.
  • Legoupil D; Dermatology Department, CHU Brest, Brest, France.
  • Saiag P; AP-HP, Dermatology, Ambroise Paré Hospital, & EA4340, UVSQ University and Paris-Saclay University, Boulogne-Billancourt, France.
  • Brunet-Possenti F; AP-HP, Dermatology, Bichat Hospital, Paris, France.
  • Arnnault JP; Dermatology Department, CHU Amiens-Picardie, Amiens, France.
  • Maubec E; Dermatology Department, Hôpital Avicenne, Bobigny, France.
  • Granel-Brocard F; Dermatology Department, CHRU Nancy, Vandoeuvre-Les-Nancy, France.
  • De Quatrebarbes J; Dermatology Department, CHR Annecy Genevois, Annecy, France.
  • Aubin F; Dermatology Department, CHU de Besançon, Besançon, France.
  • Lesimple T; Dermatology Department, CLCC Rennes Eugène Marquis, Rennes, France.
  • Beylot-Barry M; Dermatology Department, CHU Bordeaux, Bordeaux, France.
  • Stoebner PE; Dermatology Department, CHU de Nimes, Nimes, France.
  • Dupuy A; Dermatology Department, Rennes Hospital, Rennes, France.
  • Stephan A; Dermatology Department, Caen, France.
  • Grob JJ; Dermatology Department, Hopital de la Timone, Aix-Marseille University, Marseilles, France.
  • Lefevre W; AP-HP Oncodermatology Department, Saint-Louis Hospital, INSERM U976, Université de Paris, Paris, France.
  • Oriano B; Clinical Epidemiology Center, AP-HP, Hôtel-Dieu, Paris, France.
  • Allayous C; AP-HP Oncodermatology Department, Saint-Louis Hospital, INSERM U976, Université de Paris, Paris, France.
  • Lebbé C; AP-HP Oncodermatology Department, Saint-Louis Hospital, INSERM U976, Université de Paris, Paris, France.
  • Montaudié H; Dermatology Department, University Hospital of Nice, and INSERM U1065, Centre Méditerranéen de Médecine Moléculaire, Université Côte d'Azur, Nice, France. Electronic address: montaudie.h@chu-nice.fr.
Ann Oncol ; 32(4): 542-551, 2021 04.
Article em En | MEDLINE | ID: mdl-33385520
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article